Name: Kininogen 1 Rabbit Polyclonal Antibody
SKU: WP5839
Price: 268 USD
Availability: InStock

Product details

Background:

This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. Bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity. In contrast to HMWK, LMWK is not involved in blood coagulation. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2014],

Specifications

Size	50μL/100μL
Target	Kininogen 1
Reactivity	Human, Mouse, Rat
Applications	WB, IHC
MW(Calculated)
MW(Observed)	45-120kD
Host Species	Rabbit
Isotype	IgG
Conjugate/Modification	Unmodified
Recommended Dilution Ratio	IHC 1:50-200; WB 1:500-2000 / Note: For IHC, we suggest antigen retrieval with TE buffer pH 9.0 (Cat#WT1004)
Formulation	Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification	The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Storage	-15°C to -25°C/1 year(Do not lower than -25°C)
Concentration	1 mg/ml
Clonality	Polyclonal
Clone Number
Immunogen	Recombinant Protein derived from human Kininogen 1
Specificity	This antibody detects endogenous levels of human Kininogen 1
Gene Name	KNG1 BDK KNG
Protein Name	Kininogen 1
Other Name	KNG1; / BDK; / KNG; / Kininogen-1; / Alpha-2-thiol proteinase inhibitor; / Fitzgerald factor; / High molecular weight kininogen; / HMWK; / Williams-Fitzgerald-Flaujeac factor
Species	Human
Gene ID	3827
Uniprot	P01042,
Species.1	Mouse
Gene ID.1
Uniprot.1	O08677
Species.2
Gene ID.2
Uniprot.2
Cellular Localization	Secreted, extracellular space.
Tissue Expression	Secreted in plasma. T-kinin is detected in malignant ovarian, colon and breast carcinomas, but not in benign tumors.
Signaling_pathway	Cellular Processes >> Cell motility >> Regulation of actin cytoskeleton;Organismal Systems >> Immune system >> Complement and coagulation cascades;Organismal Systems >> Sensory system >> Inflammatory mediator regulation of TRP channels;Human Diseases >> Cancer: overview >> Pathways in cancer;Environmental Information Processing >> Signal transduction >> Sphingolipid signaling pathway;Environmental Information Processing >> Signal transduction >> cGMP-PKG signaling pathway
Research Areas	>>cGMP-PKG signaling pathway; / >>Sphingolipid signaling pathway; / >>Neuroactive ligand-receptor interaction; / >>Complement and coagulation cascades; / >>Inflammatory mediator regulation of TRP channels; / >>Regulation of actin cytoskeleton; / >>Chagas disease; / >>African trypanosomiasis; / >>Pathways in cancer
Function	Disease:Defects in KNG1 are the cause of high molecular weight kininogen deficiency (HMWK deficiency) [MIM:228960]. HMWK deficiency is an autosomal recessive coagulation defect. Patients with HWMK deficiency do not have a hemorrhagic tendency, but they exhibit abnormal surface-mediated activation of fibrinolysis.,Function:(1) Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.,online information:High molecular weight kininogen entry,polymorphism:The T-kinin peptide is missing residues 378 to 380, probably as a result of a naturally occurring variant. The complete sequence of the T-kinin peptide is therefore ISRPPGFSPFR. This peptide is associated with malignant tumors but not with benign ones.,PTM:Bradykinin is released from kininogen by plasma kallikrein.,PTM:Hydroxylation of Pro-383 occurs prior to the release of bradykinin.,similarity:Contains 3 cystatin domains.,tissue specificity:Plasma. T-kinin is detected in malignant ovarian, colon and breast carcinomas, but not in benign tumors.,

Please login to post questions

Kininogen 1 Rabbit Polyclonal Antibody

Product details

Specifications

About Us

Support

Order

Menu

Kininogen 1 Rabbit Polyclonal Antibody

Product details

Specifications

Related products

U-Blot® PMS2 Rabbit mAb

U-Blot® FOXO3A (Phospho Ser253) Rabbit mAb

U-Blot® NQO1 Rabbit mAb

Acetyl Lysine Monoclonal Antibody [10B10]

U-Blot® α smooth muscle actin Rabbit mAb

U-Blot® Cleaved PARP1 Rabbit mAb

Customer Reviews

Menu